Circadian Nutrition: Why Eating Windows That Are Too Short or Too Long May Shorten Lifespan

 

Time-restricted eating (TRE) and other time-based dietary patterns have gained attention for their potential benefits on metabolic health, including improved glucose regulation, better lipid profiles, and weight management. However, evidence directly linking eating window duration to long-term mortality in humans remains limited, as most prior research has focused on short-term interventions or animal studies. A recent study led by a research team at the University of Pittsburgh, published in Aging Cell, provides one of the most comprehensive analyses to date on this topic. The researchers examined how daily eating window length relates to all-cause, cardiovascular, and cancer mortality in a nationally representative cohort of U.S. adults, using longitudinal data from the National Health and Nutrition Examination Survey (NHANES) linked with mortality records.

Study method

This study analyzed data from over 33,000 U.S. adults, aged 20 and older, who participated in the NHANES survey between 2003 and 2018. Researchers used detailed food recall interviews to measure each person’s “eating window,” or the time between their first and last meal in a day. Participants were followed for more than 8 years on average, with deaths tracked through national records. The study carefully adjusted for lifestyle, health, and dietary factors like smoking, exercise, sleep, body weight, and diet quality. Advanced statistical models were applied to test how different eating window lengths related to the risk of death, including subgroup analyses by age, sex, and race.

Finding the Balance: The U-Shaped Link Between Eating Window and Mortality

The analysis revealed a clear U-shaped association between eating window duration and mortality (Fig. 1). The lowest risk was observed at an eating window of 11–12 hours per day, which served as the reference group. In contrast, individuals with shorter eating windows of less than 8 hours faced a 34% higher risk of all-cause mortality, while those with longer eating windows of 15 hours or more showed a 25% increase in mortality risk, particularly from cardiovascular causes. These associations remained robust even after adjusting for an extensive set of demographic, lifestyle, and dietary covariates. The U-shaped pattern likely reflects competing biological mechanisms: very short eating windows may restrict energy intake and nutrient diversity, predisposing some—especially older adults—to frailty and chronic disease, whereas prolonged eating windows often extend into late evening or night, disrupting circadian rhythms, impairing glucose tolerance, and elevating cardiometabolic risk. Over a median follow-up of 8.1 years, 4,158 deaths were documented, including 1,277 from cardiovascular disease and 989 from cancer. Interestingly, cancer mortality did not consistently align with eating window duration, likely due to fewer cancer-related deaths compared with cardiovascular outcomes.

 

Fig. 1: U-shaped association between eating window duration and mortality.

Circadian Nutrition: Why Eating Windows That Are Too Short or Too Long May Shorten Lifespan

 

Eating Windows and Heart Health: Stronger Links to Cardiovascular Mortality

The U-shaped association between eating window and mortality was particularly evident for cardiovascular outcomes. Individuals with shorter eating windows of less than 8 hours per day had a 50% higher risk of cardiovascular mortality (HR = 1.75; 95% CI: 1.28–2.39) in fully adjusted models. Those with longer eating windows of 15 hours or more also demonstrated a 30% increase in cardiovascular mortality risk (HR = 1.30; 95% CI: 0.90–1.87), though this association was only borderline significant. By contrast, cancer mortality showed weaker and less consistent patterns. A marginal link was observed for shorter windows (< 8 hours), with a hazard ratio of 1.08 (95% CI: 0.65–1.80), but this association diminished after full adjustment, suggesting that eating window duration may play a more prominent role in cardiovascular than in cancer-related outcomes.

Who Is Most at Risk? Subgroup Differences in Eating Window and Mortality

Subgroup analyses revealed important variability in the association between eating window duration and mortality. Among older adults (≥65 years), shorter eating windows were linked to a 40% higher all-cause mortality risk. To reduce the influence of external factors, the analysis excluded younger participants, since deaths in this group were more often related to accidents or injuries rather than diet. When focusing only on adults aged 40 and older, the pattern remained clear: individuals with very short or very long eating windows showed higher mortality, while those with moderate eating durations experienced the most favorable outcomes.  Sex-specific differences were also evident: men demonstrated a more pronounced U-shaped relationship, with shorter windows associated with a 35% higher risk of mortality compared with a weaker and nonsignificant 20% increase observed in women. Racial and ethnic differences further highlighted this heterogeneity, as White participants exhibited a steeper increase in risk with longer eating windows, whereas no significant associations were detected among Non-White groups. These findings underscore that the relationship between eating duration and mortality risk may differ substantially across demographic subgroups.

Comparison to Prior Research: Refining the Link Between Eating Window and Mortality

Previous analyses of NHANES data have reported inconsistent associations between eating window duration and mortality, reflecting methodological limitations. For example, Li et al. (2024) found that adults with the longest eating windows (>14 hours/day) had higher mortality in spline models, yet quartile-based analyses paradoxically suggested a lower risk. This discrepancy likely arose from the use of overly broad categories (≤11, 11–12.5, 12.6–14, and >14 hours/day), which obscured nuanced differences across the eating duration spectrum. Moreover, prior models often failed to account for important confounders such as overall diet quality, sleep duration, and weight-loss behaviors, limiting interpretability.

By contrast, the current study overcomes these challenges through several innovations. The application of restricted cubic spline regression allowed eating window to be treated as a continuous variable, capturing the nonlinear U-shaped relationship with greater precision. The use of narrower, biologically informed categories (e.g., <8, 11–12, ≥15 hours/day) further clarified the range associated with lowest risk. Importantly, the analysis adjusted for an extensive set of demographic, lifestyle, and dietary covariates, including the Healthy Eating Index, thereby strengthening causal inference. Granular subgroup analyses by age, sex, and race/ethnicity revealed heterogeneity in risk that earlier studies had overlooked.

Taken together, these methodological refinements provide robust evidence that moderate eating windows of 11–12 hours per day optimize longevity, whereas both shorter and longer durations increase mortality risk. This conclusion reinforces a growing body of literature on circadian-aligned eating, emphasizing the benefits of avoiding late-night meals and maintaining a balanced daily rhythm of food intake.

Limitations and Future Directions

This study has several important limitations. Dietary data were based on self-reported 24-hour recalls, which are vulnerable to recall bias and misreporting. In addition, dietary intake was measured only at baseline, limiting the ability to capture long-term changes or shifts in eating behavior. Despite adjustment for a wide range of covariates, residual confounding from unmeasured factors such as sleep quality, stress, or genetic predisposition cannot be excluded. Future research should build on these findings through randomized controlled trials with repeated dietary assessments and the integration of mechanistic approaches, such as metabolomics and circadian biology, to better clarify causal pathways.

Clinical and Public Health Implications

The findings highlight the need for a more individualized approach to dietary guidance. While an eating window of 11–12 hours per day appears broadly protective, certain subgroups—including older adults, men, and White individuals—show heightened vulnerability when eating duration falls outside this range. Public health strategies should therefore emphasize moderation and circadian alignment, discouraging both overly restrictive and excessively prolonged eating windows. Framing nutrition within the context of daily timing, in addition to diet quality, could provide a more effective path toward reducing chronic disease burden and improving population health.

Conclusion

This nationally representative analysis demonstrates a robust U-shaped association between eating window duration and mortality among U.S. adults. A moderate window of 11–12 hours per day was consistently linked to the lowest risk, whereas shorter windows increased mortality—particularly in older adults, men, and White participants—and longer windows were associated with elevated overall risk. Together, these findings underscore the importance of considering not only what and how much people eat, but also when they eat. Incorporating eating duration and timing into dietary recommendations has the potential to advance longevity-focused nutrition, pending further validation through randomized clinical trials.

Reference

Mao, Z., et al. Association of Eating Window With Mortality Among US Adults: Insights From a Nationally Representative Study. Aging Cell; Published online 13September 2025. https://doi.org/10.1111/acel.70230.

 

About Marin Biologic Laboratories

Our Recent Publication/Meeting Presentation on Gene Therapy

1. Development of VNX-101, an Adeno-Associated Virus with Less Immunogenicity and Efficient Long-Term Expression of a CD19 T-Cell Engager. Molecular Therapy Methods & Clinical Development, published online July 24, 2025.

2. Development of a Pharmacokinetic (PK) Mouse Serum GLP ELISA for an Anti–CD19–AntiCD3 Diabody
bioRxiv 2025.03.19.644217; doi: https://doi.org/10.1101/2025.03.19.644217.

3. Cell-Based Potency Assay for Anti-CD3-Anti-CD19 Diabody. bioRxiv 2025.04.15.648836v1 https://www.biorxiv.org/content/10.1101/2025.04.15.648836v1.

4. American Society of Hematology (ASH) Annual Meeting 2024.
Abstract link: Using Gene Therapy to Solve Challenges with CAR-T Cell Immunotherapy: Lead Selection and Preclinical Development of an Adeno-Associated Virus with Reduced Immunogenicity Exhibiting Efficient and Long-Term Expression of an Anti-CD19 T-Cell Engager.

Comprehensive Assay Solutions for In Vitro and Cell Based Potency Assays and Pharmacokinetics Studies- Our Expertise

With 30 years of expertise in cell culture, cell-based assays, and preclinical/clinical PK/PD analysis, we specialize in offering assay services essential for a wide variety of therapeutic drug development programs, preclinical studies, IND/BLA applications, and commercialization. Our comprehensive services include both preclinical non-GLP and GLP assays, as well as non-GMP and GMP assays, providing critical support throughout the entire development pipeline.

Watch the following video and explore our latest presentation on the development and validation of potency and pharmacokinetic (PK) assays for AAV vectors, highlighting innovative methodologies and industry-leading expertise.

 

 

Download the full presentation: Development of Custom Cell Based and In vitro Potency and Pharmacokinetics (PK) Assays for AAV vectors- Marin biologic Laboratories

 

Development of Cell-Based Potency Assays: Case Studies and Blogs from Marin Biologic Laboratories (MarinBio)

 

Drug Discovery & Development Assays Offered by Marin Biologic Laboratories (MarinBio)